Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials-Reference-Cited by-同舟云学术

Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials

Published:2018-05-17 Issue:8 Volume:12 Page:905-919
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Feagan Brian G¹,Bhayat Fatima²,Khalid Mona³,Blake Aimee³,Travis Simon P L⁴

Affiliation:

1. Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, ON, Canada

2. Global Patient Safety, Takeda Pharmaceuticals International Co., Cambridge, MA, USA

3. Evidence and Value generation, Takeda International – UK Branch, London, UK

4. Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK

Funder

Takeda Pharmaceutical Company Ltd.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/8/905/25177449/jjy047.pdf

Reference32 articles.

1. Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System;Deepak;J Gastrointestin Liver Dis,2013

2. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases;Grijalva;JAMA,2011

3. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT™ registry;Lichtenstein;Am J Gastroenterol,2012

4. Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database;McAuliffe;Curr Med Res Opin,2015

5. Safety of infliximab in Crohn’s disease: a large single-center experience;Hamzaoglu;Inflamm Bowel Dis,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Risk of Serious Infection With Vedolizumab vs Anti–Tumor Necrosis Factors in Inflammatory Bowel Disease;American Journal of Gastroenterology;2024-08-19

2. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections;Journal of Clinical Medicine;2023-10-09

3. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease;Saudi Journal of Gastroenterology;2022-11-21

4. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic;Gut;2022-04-27

5. Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre;Alimentary Pharmacology & Therapeutics;2022-04-20